GeoPolitics Pulse

The Heartbeat of World events

Tepezza approved in Japan for active thyroid eye disease – Ophthalmology Times

by ·

Amgen announced that Tepezza(teprotumumab [Genetical Recombination]) was approved by Japan’s Ministry of Health, Labour and Welfare to treat …Read More

Related posts:

  1. ChatGPT may have a future use in glaucoma – Ophthalmology Times
  2. Study shows AI may be lacking registry data – Ophthalmology Times Google Alert – Artificial General Intelligence
  3. Generative AI: It’s only just begun – Ophthalmology Times Google Alert – Artificial General Intelligence
  4. Local Disease-Free Survival and Disease-Free Survival in Locally Advanced Cervical … – Cureus Google Alert – Romania
  5. Middle East & Africa Ophthalmology Devices Market Forecast – GlobeNewswire